Skip to main content
Equibles
NEPH logo

NEPH · Nephros Inc

Track NEPH — free

Use NEPH with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about NEPH

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$4.63 -0.07 (-1.39%) At close · Aug 14
Market Cap
$50.23M
Shares
10.86M

Price & Indicators

Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$4.63 Open$4.70 Day$4.23–4.70 52W close$2.78–5.79 Avg vol 30d15K Short int37K · 0.3% float · 4.2d Short vol27% Last earningsAug 6, 2026 DataJan 2020–Aug 2026 Filing10-Q · Aug 10

Up next

Next earnings call
Oct 9, 2026 Est · unconfirmed · in 8 wks
FQ3-26 quarter ends
~Sep 30, 2026 Est
Latest filing: 10-Q
filed Aug 10, 2026

AI Brief

TL;DR.

Bullish
    Bearish

      AI-generated from the earnings call and 8-K · may contain errors · not investment advice

      Ask ALVIS about this →

      Equibles Rating

      blended score · not investment advice
      Overall
      Neutral
      SellHoldBuy
      Technical Buy Momentum Strong Sentiment Neutral Fundamentals Excellent Quant / Vol Very High
      Market backdrop VIX 14.3 · calm Equity put/call 0.52
      Technical
      price trend
      Buy
      50 / 200-day cross No cross
      Price vs 200-day avg +17%
      above
      Price vs 50-day avg +29%
      above
      RSI (14) 70
      overbought
      MACD trend Positive
      52-week position 61%
      mid-range
      Volume (OBV) Confirms
      volume backs price
      Momentum
      relative strength
      Strong
      1-month return +22%
      trailing
      6-month return +23%
      trailing
      YTD return −5%
      this year
      Relative strength +9%
      vs S&P · 6-mo
      Sentiment
      smart money
      Neutral
      Trend (MA cross) No cross
      50d $4 › 200d $4 — 200d above 50d
      Institutional flow Accumulating
      +22% holders QoQ · +7 funds added
      Insider flow Flat
      No net insider activity over 90 days
      Short interest Rising
      0.35% of float · ▲ +19.6% MoM · 4.2 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Steady
      33 holders — mid 3-yr range
      Squeeze score 59
      elevated · 0–100
      Fundamentals
      Excellent
      Revenue growth +33%
      Y/Y
      Gross margin 62%
      expanding
      EPS growth +1000%
      Y/Y
      Free cash flow $1.5M
      Valuation P/E 28.9
      rich
      Balance sheet $4.8M
      net cash
      Quant / Vol
      risk profile
      Very High
      Volatility 86%
      annualized · 1-yr
      Max drawdown −52%
      past year
      ATR 7.2%
      of price · 14-day

      Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

      Technicals

      trend & momentum for long-term holders Buy
      1 · 3 · 3
      50 / 200-day cross
      No cross Neutral
      Price vs 200-day avg
      +17% Bullish
      Price vs 50-day avg
      +29% Bullish
      RSI (14)
      70 Bearish
      MACD trend
      Positive Bullish
      52-week position
      61% Neutral
      Volume (OBV)
      Confirms Neutral
      Market signals — smart money & positioning
      Mixed
      Trend (MA cross) No cross
      50d $4 › 200d $4 — 200d above 50d
      Institutional flow Accumulating
      +22% holders QoQ · +7 funds added
      Insider flow Flat
      No net insider activity over 90 days
      Short interest Rising
      0.35% of float · ▲ +19.6% MoM · 4.2 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Steady
      33 holders — mid 3-yr range
      Price context
      position in its 52-week range
      Range low $3 Now $5 · 61% Range high $6
      vs 200-day avg +17% vs 50-day avg +29%

      Illustrative technical + ownership context — a signal mix, not investment advice.

      Key metrics

      the company's own KPIs, from written earnings releases and filings
      Metric Latest Period YoY
      Adjusted EBITDA Income non-GAAP $1.49M Six Months Ended June 30, 2026 —

      Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

      Versus peers

      Medical Instruments & Supplies — same industry group
      Open screener →
      Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
      NEPH
      Nephros Inc
      this stock
      		$50.23M -5.2% +32.7% 28.9 0.3%
      ISRG
      Intuitive Surgical Inc
      		 $139.37B -30.3% +20.5% 45.3 1.9%
      BDX
      Becton Dickinson & Co
      		 $49.96B — +8.2% — 3.7%
      MDLN
      Medline Inc.
      		 $46.99B -14.9% +11.5% — 2.6%
      ALC
      Alcon Inc
      		 $35.89B -5.8% +10.5% — 2.8%

      Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

      At a glance

      key data from every section
      Ownership
      Institutional Holders Reducing
      Holders
      33
      % held
      48.9%
      Net QoQ
      -57.1K sh
      Top holder
      WEXFORD CAPITAL LP
      Held Float
      View
      Held by Funds
      Fund positions
      13
      View
      Short & Settlement
      Short Interest Rising
      Shares short
      37.5K
      Days to cover
      4.2d
      Change
      +6.2K sh
      View
      Short Volume
      Short vol %
      27%
      As of
      Aug 14, 2026
      Short Total
      View
      Fails to Deliver
      FTD shares
      1
      Value
      $4
      As of
      Jul 10, 2026
      View
      Off-Exchange
      Off-exchange %
      56.2%
      Week of
      Jul 6, 2026
      Off-exch Lit
      View
      Financials
      Financials
      Revenue (FY)
      $18.8M
      Net income (FY)
      $1.2M
      EPS diluted
      $0.11
      View
      Filings
      SEC Filings
      Latest
      10-Q
      Filed
      Aug 10, 2026
      This year
      8
      View
      Exempt Offerings
      Offering
      $2.4M
      Filed
      Sep 7, 2021
      View
      Earnings & Events
      Earnings Calls
      Last call
      Aug 6, 2026
      View

      Performance

      5D 20D 120D MTD YTD
      NEPH +9.9% +22.4% +22.7% +36.4% -5.2%
      SPY +0.4% +4.5% +13.8% +3.9% +13.9%
      vs SPY +9.5% +17.9% +8.9% +32.5% -19.1%
      Key facts CIK 1196298 CUSIP 640671400 13F (30d) 33 filings 33 filers Visit website Investor relations

      Report a Problem

      Category
      Description
      Email (optional, for follow-up)